We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Telehealth Reduces Mortality and Emergency Admissions

By HospiMedica International staff writers
Posted on 17 Jul 2012
A new study confirms telehealth's effectiveness in improving outcomes and avoiding the need for emergency hospital care for patients with long-term conditions.

Researchers at the Nuffield Trust (London, United Kingdom), the London School of Economics and Political Science (LSE; United Kingdom), and other institutions conducted a pragmatic, multisite, cluster randomized trial involving 3,230 people--1,570 intervention group and 1,584 control patients--with diabetes, chronic obstructive pulmonary disease (COPD), or heart failure recruited from 179 general practices in England between May 2008 and November 2009. More...
Telehealth interventions involved remote exchange of data between patients and healthcare professionals as part of patients’ diagnosis and management. The main outcome measure was the proportion of patients admitted to hospital during the 12-month trial period.

The results showed that compared with controls, the intervention group presented a 45% reduction in mortality rate; a 20% reduction in emergency admissions; 15% fewer accident and emergency departments (A&E) visits; a 14% reduction in bed days; and an 8% reduction in tariff costs. The differences in emergency admissions were greatest at the beginning of the trial, during which the researchers observed a particularly large increase for the control group. Observed differences in other forms of hospital use, including notional costs, were not significant in general. The study was published on June 21, 2012, in BMJ.

“Telehealth is associated with lower mortality and emergency admission rates. The reasons for the short term increases in admissions for the control group are not clear, but the trial recruitment processes could have had an effect,” concluded lead author Adam Steventon, a senior research analyst at the Nuffield Trust, and colleagues.

“This paper confirms that telehealth significantly reduces deaths, helps patients to avoid the need for emergency hospital admissions, and shortens hospital stays when compared with traditional approaches to care,” added Simon Arnold, Managing Director of Tunstall Healthcare (London, United Kingdom), a supplier of telehealthcare solutions. “This is absolutely complementary to our work with partners across the UK and provides an indisputable evidence base for clinicians and commissioners when making decisions about patient care in the future.”

Related Links:

Nuffield Trust
London School of Economics and Political Science
Tunstall Healthcare



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.